Pulse Biosciences Enters $60 Million Equity Distribution Agreement
Express News | Pulse Biosciences Inc -May Offer and Sell Shares of Our Common Stock Aggregate Offering Price of up to $60 Mln From Time to Time Through Agents
Express News | Pulse Biosciences Inc - Entered Into Equity Distribution Agreement Relating to Offer and Sale of Shares of Common Stock
Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
Sector Update: Health Care Stocks Softer Late Afternoon
Top Midday Gainers
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Pulse Stock Rallies 22% on FDA Breakthrough Designation
Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
Express News | Pulse Biosciences Shares Are Trading Higher After the Company Announced It Received the Breakthrough Device Designation From the FDA for Its Cardiac Surgery System for the Ablation of Cardiac Tissue for the Treatment of Atrial Fibrillation
Pulse Biosciences Gets FDA's Breakthrough Status for Surgery System
Express News | Pulse Biosciences Receives FDA Breakthrough Device Designation For Cardiac Surgery System Using Nanosecond Pulsed Field Ablation Technology For Treating Atrial Fibrillation
Express News | Pulse Biosciences Inc - to Begin Pivotal Clinical Trial for Af in 2025
Express News | Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for Cellfx® Nspfa Cardiac Surgery System for the Treatment of Atrial Fibrillation
Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX NsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation
Pulse Biosciences, Inc. Announces the Closing of Its Rights Offering
Pulse Biosciences Received Basic Subscriptions and Over-Subscriptions in Excess of $83M >PLSE
Express News | Pulse Biosciences Inc: Oversubscribed Offering Expected to Generate $60 Mln in Immediate Proceeds
Express News | Pulse Biosciences Inc - Warrants Could Generate up to $66 Million
Pulse Biosciences, Inc. Announces Preliminary Results for Its Rights Offering